Internal Medicine · Trenton, NJ
NPI
1215974902
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2055 Klockner Rd
Trenton, NJ, 08690
Phone (609) 586-8060
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
1,022 services
Medicare patients, 2024
109
Average age 77
Drug cost, 2024
$1.5M
5,365 prescriptions
Company payments, 2025
$6,257
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward B Laub was code 99214 (office e&m - established), 484 times for 95 patients. In total Edward B Laub billed 1,022 services in 23 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 484 | 95 | $94.31 | $46K |
| 99441 Telephone Services | Office | 138 | 66 | $34.92 | $4,819 |
| G0008 Administration of influenza virus vaccine | Office | 70 | 69 | $34.22 | $2,395 |
| 90662 Vaccine Product | Office | 69 | 68 | $81.39 | $5,616 |
| 93000 Electrocardiogram | Office | 38 | 36 | $10.81 | $411 |
| 90480 Vaccine Administration | Office | 34 | 34 | $45.08 | $1,533 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 34 | 34 | $136.25 | $4,633 |
| 91320 Vaccine Product | Office | 33 | 33 | $152.78 | $5,042 |
| 99213 Office E&M - Established | Office | 32 | 28 | $66.92 | $2,142 |
| 90677 Vaccine Product | Office | 19 | 19 | $279.30 | $5,307 |
| G0009 Administration of pneumococcal vaccine | Office | 19 | 19 | $29.40 | $559 |
By year: 2022 $71K for 953 services; 2023 $74K for 927 services; 2024 $83K for 1,022 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward B Laub prescribed most often to Medicare patients was Rosuvastatin Calcium, with 584 prescriptions and refills. In total Edward B Laub wrote 5,365 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 584 | 1,457 | 138 | $8,314 |
| Ezetimibe Generic | 252 | 543 | 64 | $5,313 |
| Farxiga Dapagliflozin Propanediol | 175 | 287 | 33 | $156K |
| Icosapent Ethyl Generic | 145 | 317 | 43 | $65K |
| Kerendia Finerenone | 134 | 225 | 24 | $139K |
| Escitalopram Oxalate Generic | 132 | 338 | 40 | $1,671 |
| Levothyroxine Sodium Generic | 117 | 284 | 25 | $1,018 |
| Jardiance Empagliflozin | 117 | 203 | 22 | $115K |
| Metoprolol Succinate Generic | 95 | 259 | 27 | $1,970 |
| Amlodipine Besylate Generic | 95 | 276 | 27 | $863 |
| Omeprazole Generic | 90 | 228 | 29 | $1,271 |
| Losartan Potassium Generic | 82 | 192 | 20 | $519 |
| Metformin Hcl Er Metformin Hcl | 80 | 152 | 24 | $839 |
| Rybelsus Semaglutide | 77 | 80 | 13 | $72K |
| Repatha Sureclick Evolocumab | 77 | 123 | 13 | $68K |
Brand drugs: 1,413 claims; generic drugs: 3,918 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward B Laub $6,257 ($6,257 in general payments such as food, travel and fees) from 33 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,250.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $1,250 |
| Sekisui Diagnostics LLC | 1 | $1,200 |
| Abbvie Inc. ABBV | 20 | $487 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $385 |
| Novo Nordisk AS NVO | 1 | $355 |
| Axsome Therapeutics, Inc. AXSM | 9 | $332 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 18 | $291 |
| Amgen Inc. AMGN | 18 | $267 |
| Novo Nordisk Inc NVO | 12 | $262 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $201 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.